Cost-effectiveness of Tamoxifen, Aromatase Inhibitor, and Switch Therapy (Adjuvant Endocrine Therapy) for Breast Cancer in Hormone Receptor Positive Postmenopausal Women in India

BACKGROUND: Breast cancer is the leading cause of cancer among women in India. Treatment with hormone therapy reduces recurrence. We undertook this cost-effectiveness study to ascertain the treatment option offering the best value for money. METHODS: The lifetime costs and health outcomes of using t...

Descripción completa

Detalles Bibliográficos
Autores principales: Butani, Dimple, Gupta, Nidhi, Jyani, Gaurav, Bahuguna, Pankaj, Kapoor, Rakesh, Prinja, Shankar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636459/
https://www.ncbi.nlm.nih.gov/pubmed/34866937
http://dx.doi.org/10.2147/BCTT.S331831

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636459/
https://www.ncbi.nlm.nih.gov/pubmed/34866937
http://dx.doi.org/10.2147/BCTT.S331831

Ejemplares similares